---
title: "LAYANSON3 PHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1fec2899-5224-415d-97e4-fa3ab0fdfa50
json: https://whiteintel.dev/api/public/dossier/1fec2899-5224-415d-97e4-fa3ab0fdfa50
identifier: gb-coh:16330278
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LAYANSON3 PHARMA LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:16330278`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1fec2899-5224-415d-97e4-fa3ab0fdfa50  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1fec2899-5224-415d-97e4-fa3ab0fdfa50  

## Ownership & control

### Owners / controllers

- **LAYANSON2 PHARMA LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4a539170-310f-4b32-85fa-a432339998d7
- **AVICENNA RETAIL LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/930faeff-db84-5524-b0ed-44cdfbc4bc4b

### UBO chain (walk to the ultimate owner)

A **15-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `16330278`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2025-03-20
- **Registered office:** 3 Bramley Road, Thornbury, Bristol, BS35 1EY, England
- **SIC:** 47730, 47741, 47750

### Officers

- LAYADE, Adedamola — secretary · appointed 2025-12-02
- LAYADE, Adedamola Ifeolwa — director · British · appointed 2025-12-02
- GILDER, David Robert — director · British · appointed 2025-03-20 · resigned 2025-12-02
- WRIGHT, Jake Hockley — director · British · appointed 2025-03-20 · resigned 2025-12-02

### Beneficial owners (Persons with Significant Control)

- [Layanson2 Pharma Ltd](https://whiteintel.dev/entity/4a539170-310f-4b32-85fa-a432339998d7) — 75–100% shares · corporate PSC · England — since 2025-12-02
- [Avicenna Retail Ltd](https://whiteintel.dev/entity/930faeff-db84-5524-b0ed-44cdfbc4bc4b) — 75–100% shares · corporate PSC · United Kingdom — ceased 2025-12-02

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/16330278

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LAYANSON3 PHARMA LTD**. Human view: https://whiteintel.dev/entity/1fec2899-5224-415d-97e4-fa3ab0fdfa50 · Structured JSON: https://whiteintel.dev/api/public/dossier/1fec2899-5224-415d-97e4-fa3ab0fdfa50._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._